Tomas O Jensen
Overview
Explore the profile of Tomas O Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mourad A, Grandits G, Siegel L, Engen N, Barkauskas C, Eriobu N, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39922466
Objectives: Passive immunotherapy, including monoclonal antibodies and neutralizing proteins, was used for the treatment of patients with COVID-19 during the pandemic. Accelerating COVID-19 Therapeutic Interventions and Vaccines-Therapeutics for Inpatients with...
2.
Keshtkar-Jahromi M, Adam S, Brar I, Chung L, Currier J, Daar E, et al.
J Clin Transl Sci
. 2024 Nov;
8(1):e152.
PMID: 39540114
The United States Government (USG) public-private partnership "Accelerating COVID-19 Treatment Interventions and Vaccines" (ACTIV) was launched to identify safe, effective therapeutics to treat patients with Coronavirus Disease 2019 (COVID-19) and...
3.
Jensen T, Harper K, Gupta S, Liu S, Dharan N, Baker J, et al.
Clin Infect Dis
. 2024 Sep;
79(6):1394-1403.
PMID: 39271151
Background: Extrapulmonary complications (EPCs) are common in patients hospitalized for coronavirus disease 2019 (COVID-19), but data on their clinical consequences and association with viral replication and systemic viral dissemination are...
4.
Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, et al.
J Infect Dis
. 2024 Sep;
PMID: 39269490
Background: Biomarker guided therapy could improve management of COVID-19 inpatients. Although some results indicate that antibody tests are prognostic, little is known about patient management using point-of-care (POC) antibody tests....
5.
Jensen T, Murray T, Grandits G, Jain M, Grund B, Shaw-Saliba K, et al.
Lancet Microbe
. 2024 May;
5(6):e559-e569.
PMID: 38815595
Background: Serial measurement of virological and immunological biomarkers in patients admitted to hospital with COVID-19 can give valuable insight into the pathogenic roles of viral replication and immune dysregulation. We...
6.
Jensen T, Grandits G, Jain M, Murray T, Grund B, Shaw-Saliba K, et al.
J Infect Dis
. 2023 Nov;
229(3):671-679.
PMID: 37948759
Background: Neutralizing monoclonal antibodies (nmAbs) failed to show clear benefit for hospitalized patients with coronavirus disease 2019 (COVID-19). Dynamics of virologic and immunologic biomarkers remain poorly understood. Methods: Participants enrolled...
7.
Lamrous A, Repetto E, Depp T, Jimenez C, Chua A, Kanapathipillai R, et al.
JAC Antimicrob Resist
. 2023 May;
5(3):dlad057.
PMID: 37206308
Objectives: C-reactive protein (CRP) and procalcitonin (PCT) are widely used biomarkers in high-income countries. However, evidence for their use in low- and middle-income countries (LMICs) is scant. Because many factors,...
8.
Gronbaek K, Rasmussen S, Langer N, Vincentz M, Oxboll A, Sogaard M, et al.
Acta Anaesthesiol Scand
. 2023 Feb;
67(5):640-648.
PMID: 36852515
Background: Patients admitted to the emergency care setting with COVID-19-infection can suffer from sudden clinical deterioration, but the extent of deviating vital signs in this group is still unclear. Wireless...
9.
Lauridsen K, Olsen K, Lund E, Jensen T, Pedersen T, Harboe Z, et al.
Clin Pathol
. 2022 Nov;
15:2632010X221139096.
PMID: 36448025
Background: Neurological complications during and after SARS-CoV-2 infection have been frequently described. The detection of either SARS-CoV-2 RNA or specific antibodies against SARS-CoV-2 in cerebrospinal fluid in the context of...
10.
Radziwon-Balicka A, Wiwe E, Jensen T, Nielsen S, Copois M, Sunde N, et al.
Clin Chim Acta
. 2022 Oct;
537:87-95.
PMID: 36279940
Background: The objective of our study was to evaluate a single blood collection tube with a novel antithrombotic formulation to measure both hematological, biochemical, and d-dimer analytes. Methods: Paired samples...